Cogience.LifeSciences

We help our clients to solve the economic challenges of modern healthcare by identifying, developing and commercialising cost effective treatments to improve patients health related quality of life.

We specialise in

Pricing Reimbursement and Market Access
Health Economics and Outcomes Research
Asset Evaluation and Due Diligence

Unique Skills and Experience

With expertise in Pharmaceuticals, Biotechnology and Medical Devices,
we are able to leverage the knowledge, tools and best practices across industries

Cogience.LifeSciences – Value Proposition

Optimize Your Strategy and Success

 We help clients to understand and navigate the complexities of market access in biotechnology, medical devices and pharmaceuticals.

With a global reach and diverse expertise, we are uniquely placed to help clients to create and maximise the value of their assets though commercially focused market access strategies

 

Cogience.LifeSciences – Service Offering

What We Can Do For You

We help our clients to solve the economic challenges of modern healthcare by identifying, developing and commercialising cost effective treatments to improve patients health related quality of life.

Pricing and Reimbursement

Market Access

Health Economics

Outcomes Research

Asset Evaluation

Due Diligence

COGIENCE.LIFESCIENCES – SERVICE DETAILS

Pricing Reimbursement and Market Access

Strategy Development

  • Develop global and regional pricing strategy
  • Qualitative and quantitative payer research
  • Therapeutic area Payer advisory boards
  • International Reference Pricing (IRP) & launch strategy
  • Individual case study & benchmark analysis
  • Secondary market research using big data analytics

Strategy Implementation

  • Bespoke IRP database & price tracking system
  • Local country/regional dossier preparation
  • Management of local reimbursement process
  • Stakeholder & influencer mapping
  • KoL development
  • Patient advocacy

Health Economics and Outcomes Research

  • Burden of illness study
  • Cost effectiveness evaluation
  • Global Value Dossier
  • Clinical trial design to maximise value of asset
  • Observational studies
  • Testing & evaluation of economic models
  • Health Technology Assessment advisory boards

Asset Evaluation and Due Diligence

  • Competitive landscape assessment
  • Global value proposition
  • Product valuations for out-licensing
  • Comprehensive due diligence documents